Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioMerieux, a developer of diagnostic systems, has acquired PML Microbiologicals, a provider of culture media and microbiological products in North America for both clinical and industrial applications.
Subscribe to our email newsletter
BioMerieux has purchased 100% of PML Microbiologicals’s shares from the privately held Pelican Life Sciences Group, based in San Diego, California (US) for $29.6 million.
The acquisition will enable BioMerieux to become a leading provider in the US of microbiology testing solutions for pharmaceutical companies. In addition, BioMerieux will enter the North American clinical prepared culture media (PPM) market, becoming the number one PPM provider for clinical applications in Canada.
PML’s sites in Portland and Toronto will join BioMerieux’s worldwide network of culture media production centers with its main site in Craponne (France) and regional facilities in Lombard, Illinois (US), Madrid (Spain), Basingstoke (England), Brisbane (Australia) and Rio de Janeiro (Brazil).
Stephane Bancel, CEO of BioMerieux, said: “This new acquisition, our sixth in two years, reinforces the North American market position of BioMerieux’s core business, microbiology. In the current challenging economic context, we are pleased to add another reagent-only business to our portfolio that will boost BioMerieux’s recurring sales.”